Myomo (MYO) Gross Profit Growth (3y) (2019 - 2025)
Myomo (MYO) Gross Profit Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 9.77% |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 12.24% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 14.82% |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 9.36% |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 14.95% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 3.96% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.99% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 8.95% |
| 10 | Myomo | 74.64 Mn | 55.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 34.68% |
| Jun 30, 2025 | 36.09% |
| Mar 31, 2025 | 36.88% |
| Dec 31, 2024 | 40.26% |
| Sep 30, 2024 | 28.50% |
| Jun 30, 2024 | 34.21% |
| Mar 31, 2024 | 10.30% |
| Dec 31, 2023 | 3.72% |
| Sep 30, 2023 | 48.22% |
| Jun 30, 2023 | 113.53% |
| Mar 31, 2023 | 49.58% |
| Dec 31, 2022 | 33.84% |
| Sep 30, 2022 | 111.84% |
| Jun 30, 2022 | 68.68% |
| Mar 31, 2022 | 68.03% |
| Dec 31, 2021 | 67.59% |
| Sep 30, 2021 | 99.00% |
| Jun 30, 2021 | 72.13% |
| Mar 31, 2021 | 102.91% |
| Dec 31, 2020 | 100.84% |